Sites in the CH3 domain of human IgA1 that influence sensitivity to bacterial IgA1 proteases

Journal of Immunology

Volumn 177, Issue 6, 2006, Pages 3913-3919

  Senior, Bernard W ^a   Woof, Jenny M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; GLUTAMINE; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN G1; PHENYLALANINE; PROLINE; PROTEINASE; THREONINE;

ARTICLE; BINDING SITE; GENE DELETION; HAEMOPHILUS INFLUENZAE; HUMAN; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN MOTIF; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS SANGUINIS;

EID: 33748514799     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.6.3913     Document Type: Article

References (43)

1. Plaut, A. G. 1983. The IgA1 proteases of pathogenic bacteria. Annu. Rev. Microbiol. 37: 603-622.
2. Senior, B. W., L. M. Loomes, and M. A. Kerr. 1991. Microbial IgA proteases and virulence. Rev. Med. Microbiol 2: 200-207.
3. Kilian, M., J. Reinholdt, H. Lomholt, K. Poulsen, and E. V. G. Frandsen. 1996. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS 104: 321-338.
4. Blake, M., K. K. Holmes, and J. Swanson. 1979. Studies on gonococcus infection. XVII. IgA1-cleaving protease in vaginal washings from women with gonorrhea. J. Infect. Dis. 139: 89-92.
5. Kilian, M., J. Reinholdt, S. B. Mortensen, and C. H. Sorensen. 1983. Perturbation of mucosal immune defence mechanisms by bacterial IgA proteases. Bull. Eur. Physiopathol. Respir. 19: 99-104.
6. Ahl, T., and J. Reinholdt. 1991. Detection of immunoglobulin A1 protease-induced Fabα fragments on dental plaque. Infect. Immun. 59: 563-569.
7. Brooks, G. F., C. J. Lammel, M. S. Blake, B. Kusecek, and M. Achtman. 1992. Antibodies against IgA protease are stimulated both by clinical disease and asymptomatic carriage of serogroup A Neisseria meningitidis. J. Infect. Dis. 166: 1316-1321.
8. Devenyi, A. G., A. G. Plaut, F. J. Grundy, and A. Wright. 1993. Post-infectious human serum antibodies inhibit IgA1 proteinases by interaction with the cleavage site specificity determinant. Mol. Immunol. 30: 1243-1248.
9. Gilbert, J. V., A. G. Plaut, B. Longmaid, and M. E. Lamm. 1983. Inhibition of microbial IgA proteases by human secretory IgA and serum. Mol. Immunol. 20: 1039-1049.
10. Mulks, M. H., and A. G. Plaut. 1978. IgA protease production as a characteristic distinguishing pathogenic from harmless Neisseriaceae. New Engl. J. Med. 299: 973-976.
11. Kilian, M., J. Mestecky, and J. E. Schrohenloher. 1979. Pathogenic species of the genus Haemophilus and Streptococcus pneumoniae produce immunoglobulin A1 protease. Infect. Immun. 26: 143-149.
12. Hauck, C. R., and T. F. Meyer. 1997. The lysosomal/phagosomal membrane protein h-lamp-1 is a target of the IgAl protease of Neisseria gonorrhoeae. FEBS Lett. 405: 86-90.
13. Lin, L., P. Ayala, J. Larson, M. Mulks, M. Fukuda, S. R. Carlsson, C. Enns, and M. So. 1997. The Neisseria type 2 IgA1 protease cleaves LAMP1 and promotes survival within epithelial cells. Mol. Microbiol. 24: 1083-1094.
14. Beck, S. C., and T. F. Meyer. 2000. IgA1 protease from Neisseria gonorrhoeae inhibits TNFα-mediated apoptosis of human monocytic cells. FEBS Lett. 472: 287-292.
15. Senior, B. W., W. W. Stewart, C. Galloway, and M. A. Kerr. 2001. Cleavage of the hormone human chorionic gonadotropin, by the type 1 IgA1 protease of Neisseria gonorrhoeae, and its implications. J. Infect. Dis. 184: 922-925.
16. Qiu, J., G. P. Brackee, and A. G. Plaut. 1996. Analysis of the specificity of bacterial immunoglobulin A (IgA) proteases by a comparative study of ape serum IgAs as substrates. Infect. Immun. 64: 933-937.
17. Janoff, E. N., J. B. Rubins, C. Fasching, A. Plaut, and J. N. Weiser. 2002. Inhibition of IgA-mediated killing of S. pneumoniae (SPN) by IgA1 protease (IgA1P). 11th International Congress of Mucosal Immunology. Mucosal Immunol. Update 10: Abstr. 2839.
18. Weiser, J. N., D. Bae, C. Fasching, R. W. Scamurra, A. J. Ratner, and E. N. Janoff. 2003. Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc. Natl. Acad. Sci. USA 100: 4215-4220.
19. Kilian, M., J. Mestecky, and M. W. Russell. 1988. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol. Rev. 52: 296-303.
20. Mansa, B., and M. Kilian. 1986. Retained antigen-binding activity of Fabα fragments of human monoclonal immunoglobulin A1 (IgA1) cleaved by IgA1 protease. Infect. Immun. 52: 171-174.
21. Lorenzen, D. R., F. Dux, U. Wolk, A. Tsirpouchtsidis, G. Haas, and T. F. Meyer. 1999. Immunoglobulin A1 protease, an exoenzyme of pathogenic Neisseriae, is a potent inducer of proinflammatory cytokines. J. Exp. Med. 190: 1049-1058.
22. Chintalacharuvu, K. R., P. D. Chuang, A. Dragoman, C. Z. Fernandez, J. Qiu, A. G. Plaut, K. R. Trinh, F. A. Gala, and S. L. Morrison. 2003. Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA. Infect. Immun. 71: 2563-2570.
23. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77: 61-68.
24. Atkin, J. D., R. J. Pleass, R. J. Owens, and J. M. Woof. 1996. Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly. J. Immunol. 157: 156-159.
25. Pleass, R. J., J. I. Dunlop, C. M. Anderson, and J. M. Woof. 1999. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human Fcα receptor (FcαR) CD89. J. Biol. Chem. 274: 23508-23514.
26. Kabat, E. A., T. T. Wu, M. Reid-Miller, H. Perry, and K. S. Gottesman. 1987. Sequences of Proteins of Immunological Interest. 4th Ed. U.S. Department of Health and Human Services, National Institutes of Health, Washington, D.C.
27. Morton, H. C., J. D. Atkins, R. J. Owens, and J. M. Woof. 1993. Purification and characterization of chimeric human IgA1 and IgA2 expressed in COS and Chinese hamster ovary cells. J. Immunol. 151: 4743-4752.
28. Pleass, R. J., P. K. Dehal, M. J. Lewis, and J. M. Woof. 2003. Limited role of charge matching in the interaction of human immunoglobulin A with the immunoglobulin A Fc receptor (FcαRI) CD89. Immunology 109: 331-335.
29. Senior, B. W., and J. M. Woof. 2005. The influences of structure and size of the human IgA hinge on its susceptibility to cleavage with diverse bacterial IgA1 proteases. J. Immunol. 174: 7792-7799.
30. Batten, M. R., B. W. Senior, M. Kilian, and J. M. Woof. 2003. Amino acid sequence requirements in the hinge of human immunoglobulin A1 (IgA1) for cleavage by streptococcal IgA1 proteases. Infect. Immun. 71: 1462-1469.
31. Senior, B. W., and J. M. Woof. 2005. Effect of mutations in the human immunoglobulin A1 (IgA1) hinge on its susceptibility to cleavage by diverse bacterial IgA1 proteases. Infect. Immun. 73: 1515-1522.
32. Wood, S. G., and J. Burton. 1991. Synthetic peptide substrates for the immunoglobulin A1 protease from Neisseria gonorrhoeae (Type 2). Infect. Immun. 59: 1818-1822.
33. Lomholt, H., K. Poulsen, and M. Kilian. 1995. Comparative characterisation of the iga gene encoding IgA1 protease in Neisseria meningitidis, Neisseria gonorrhoeae and Haemophilus influenzae. Mol. Microbiol. 15: 495-506.
34. Carayannopoulos, L., J. M. Hexham, and J. D. Capra. 1996. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Cα2 and Cα3 in human IgA1. J. Exp. Med. 183: 1579-1586.
35. Herr, A. B., E. R. Ballister, and P. J. Bjorkman. 2003. Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc. Nature 423: 614-620.
36. Pleass, R. J., T. Areschoug, G. Lindahl, and J. M. Woof. 2001. Streptococcal IgA-binding proteins bind in the Cα2-Cα3 interdomain region and inhibit binding of IgA to human CD89. J. Biol. Chem. 276: 8197-8204.
37. Wines, B. D., N. Willoughby, J. D. Fraser, and P. M. Hogarth. 2006. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, FcαRI, is revealed by SSL7 binding at the Cα2/Cα3 interface of IgA. J. Biol. Chem. 281: 1389-1393.
38. Burton, D. R. 1985. Immunoglobulin G: functional sites. Mol. Immunol. 22: 161-206.
39. DeLano, W. L., M. H. Ultsch, A. M. De Vos, and J. A. Wells. 2000. Convergent solutions to binding at a protein-protein interface. Science 287: 1279-1283.
40. Hexham, J. M., K. D. White, L. N. Carayannopoulous, W. Mandecki, R. Brisette, Y. S. Yang, and J. D. Capra. 1999. A human immunoglobulin (Ig) A Cα3 domain motif directs polymeric Ig receptor-mediated secretion. J. Exp. Med. 189: 747-752.
41. Lewis, M. J., R. J. Pleass, M. R. Batten, J. D. Atkin, and J. M. Woof. 2005. Structural requirements for the interaction of human IgA with the human polymeric Ig receptor. J. Immunol. 175: 6694-6701.
42. Reinholdt, J., M. Tomana, S. B. Mortensen, and M. Kilian. 1990. Molecular aspects of immunoglobulin A1 degradation by oral streptoccoci. Infect. Immun. 58: 1186-1194.
43. Boehm, M. K., J. M. Woof, M. A. Kerr, and S. J. Perkins. 1999. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron scattering and homology modelling. J. Mol. Biol. 286: 1421-1447.